Loading market data...
Latest Top News
Aurobindo Pharma Receives ₹776.1 Million Tax Demand, Equal Penalty Imposed
Aurobindo Pharma Ltd has received a tax demand and penalty order amounting to ₹776.1 million each. The development highlights ongoing regulatory scrutiny in India’s pharmaceutical sector, raising concerns over compliance, financial impact, and investor sentiment as the company navigates complex tax and legal challenges.
Stay Ahead – Explore Now! White House Restricts Foreign Access to Anthropic's Frontier AI Models






